Skip to main content

AIDE: A Randomized Cross-Over Trial Evaluating Automated Insulin Delivery (AID) Technologies on Hypoglycemia and Quality of Life (QOL) in Elderly Adults with Type 1 Diabetes (T1D)

AIDE: A Randomized Cross-Over Trial Evaluating Automated Insulin Delivery (AID) Technologies on Hypoglycemia and Quality of Life (QOL) in Elderly Adults with Type 1 Diabetes (T1D)

Associated Conditions

Diabetes, Type 1

Principal Investigator

Sponsor

JAEB CENTER FOR HEALTH RESEARCH

To determine how safe and effective hybrid closed-loop and predictive low glucose suspend insulin pump technologies are for patients aged 65 and older with type 1 diabetes, and learn the effect they have on hypoglycemia in this population.

To be enrolled in this study, you must meet certain requirements. You may be eligible to participate if you meet the following criteria:

Study Commitment: ~54 weeks

Age: 65 years old

Sex: Male & Female

Conditions/Eligibility: 

  • Clinical diagnosis of T1D 
  • Age ≥ 65 years old 
  • Type 1 diabetes duration of at least 1 year
  • HbA1c < 10.0% from point of care or local lab within 6 months
  • Insulin regimen involves basal/bolus insulin via insulin pump or multiple daily injections 
  • Ability to download study devices at home or willing to come into clinic for devices to be downloaded at visits and when needed for safety
  • No use of hybrid closed loop or predictive low glucose suspend insulin pump technology within 3 months of screening

Study Procedures:

  • Vital signs
  • Physical examination
  • Fingersticks or blood draws
  • Review of medical history and medications
  • Cognitive assessment questionnaires

Upon confirmation of eligibility, study participant will receive an insulin pump and continuous glucose monitor to wear for the duration of study participation.

Compensation: Up to $450.00

This study is currently enrolling.


Interested in Participating?

Please call (407) 303-7193 or fill out the Contact Form below for more information.